Vitamin C preferentially kills cancer cells, and makes you resistant to bacterial infections. Vitamin C is toxic to cancer cells both in vitro and in vivo. It selectively kills cancer cells like chemo agents, but requires large amounts of vitamin C. (Riordan, Project RECNAC, Bio-Communications Research Institute).

As early as 1971 (Cameron and Pauling), and more recently Morishige, showed high doses of ascorbic acid (Vitamin C) was successful in treating cancers. Pauling is one of the twenty most important scientists of all time had 2 unshared Nobel Prizes, and contributed numerous studies in biology, chemisty and physics. He authored many articles showing terminal cancer patients lived as much as ten times longer when treated with Vitamin C.

Cancer drugs have been used successfully since 1950 for Hodgkin’s, leukemia, and testicular tumors. Cancer drugs or combination of cancer drugs does not affect most of the other common cancers. At that time, only oral ascorbic acid was given, and not in high doses.


Because normal and cancer cells are very similar and born from the same host, most cancer drugs also kill normal cells. To get a remission, cancer drugs are pushed to toxic levels.

This results in hair loss, nausea and vomiting, heart toxicity, and secondary cancer development. The bone marrow is suppressed, causing suppression of your immunity and blood cells. This results in infections being the major cause of death from cancer.

A safety gap between normal and cancer cells is present in drugs that make hydrogen peroxide. Vitamin C belongs in this class of substances that when given at a correct does, can kill tumor cells with no toxic effects to you the patient.


Plasma vitamin C levels can stay at the level required to kill 100% of cancer cells for a long time, but it requires the Vitamin C be given intravenously. It preferentially kills cancer cells, is non-toxic at any dose, and does not suppress your immune system. It increases your lymphocyte and neutrophil white counts, making you resistant to bacterial infections.

The matrix outside of the cells is strengthened, keeping the stroma resistant to cancer cells. The breakdown products of Vitamin c also show anticancer activity. ( Bram 1977, Helgestad 2004, Park 1980)

Injecting ascorbic acid (Vitamin C) under the skin helped the chemotherapy in advanced lung cancers in mice. Orally, it blocked the DNA and RNA in melanoma cancer, sarcomas. Copper 2+, in the presence of ascorbic acid and helps hydrogen peroxide (hydroxyl radical0 production.


Oncologists quote old studies at Mayo by Creagan, who was skeptical such high levels of ascorbic acid and copper ions could be maintained to kill cancer cells, and questioned if the vitro studies could be true in vivo.

Recently, (Tsao), is reported that oral ionic copper, added to the success of ascorbic acid in cancers. The exact dose of vitamin C needed to kill cancers must still be determined.


Pauling stated: “Every patient with cancer, beginning as early in the course of the disease as possible, should be taking 10, 12 or even more grams of vitamin C, 800 units of vitamin E, large amounts of the other vitamins and 200 mcg per day of selenium."

Pauling added: "This should be an adjunct to appropriate conventional therapy, where "appropriate" means conventional therapy that has been shown to have value for patients with the same kind of cancer”.


Many publications (Klenner, Cathcart, Rivers) show high doses of ascorbic acid by mouth are safe and non-toxic. There is sufficient evidence to support use of ascorbic acid (vitamin C) intravenously in high doses as a cancer chemo agent. Oncologists should revisit vitamin C as a possible agent in their cancer treatments, as Linus Pauling urged.


Contact Me

HTML verification file. [google5d886e9132194e54.html]